Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin Monotherapy
InSightec
InSightec
Children's Oncology Group
InSightec
Children's Oncology Group
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
The University of Hong Kong
Northwell Health
The Hospital for Sick Children
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Albert Einstein College of Medicine
Novartis
Henry Ford Health System
Sun Yat-sen University
Children's Hospital Los Angeles
Children's Oncology Group
CarThera
Children's Oncology Group
OHSU Knight Cancer Institute
National Cancer Institute (NCI)
University of Colorado, Denver
NYU Langone Health
Children's Oncology Group
Roswell Park Cancer Institute
Novartis
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Children's Oncology Group
St. Jude Children's Research Hospital
Assistance Publique - Hôpitaux de Paris
Samsung Medical Center
Children's Oncology Group
University Hospital, Bonn
Ohio State University Comprehensive Cancer Center
Children's Oncology Group
Societe Internationale d'Oncologie Pediatrique
Children's Oncology Group
St. Jude Children's Research Hospital
Ohio State University Comprehensive Cancer Center
MedImmune LLC
Children's Oncology Group
City of Hope Medical Center
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group
Children's Oncology Group